Alterations in the intracellular distribution of TDP-43 were observed in the skeletal muscles of patients suffering from ALS. However, it is not clear whether these modifications play an active role in the disease or represent a physiological adaptation to muscles homeostasis.
we observed that the expression of an RNAi against TBPH (TBi) with Mhc-GAL4 or Mef2-GAL4 significantly affected the locomotor capacities of the treated flies at both larval and adult stages ( Fig. 1a and b ). Moreover, we found that the life span of the Mef2-GAL4, TBi expressing flies was strongly compromised compared to the Mef2-GAL4, GFP-RNAi expressing controls (GFPi) (Fig. 1c ). In addition, we observed that the reduction of one copy of the endogenous gene was able to enhance the locomotive defects occasioned by the expression of TBi (Mhc-GAL4, TBPH -/+, TBi vs Mhc-GAL4, TBPH -/+, GFP-RNAi) indicating that these phenotypes were gene dose sensitive and, therefore, rather specific ( Fig. 1a) . At the cellular level, we found that the expression of TBi strongly affected the organization of the neuromuscular synapses including the localization of the postsynaptic proteins present in the muscular membranes ( Fig. 1d-g ). More specifically, we observed that the intensity levels of the postsynaptic protein Disc-large (Dlg) were strongly reduced in TBPH-RNAi treated muscles compared to controls with the presence of numerous, pathological, gaps in the distribution of Dlg around the motoneurons axons ( Fig. 1d and e ). Furthermore, we detected that the postsynaptic distribution and clustering of the glutamate receptors (GluRIIA) were impaired in the RNAi treated flies related to controls indicating that the muscular function of TBPH is required to prevent the disorganization of the postsynaptic membranes ( Fig. 1f and g) . Furthermore, we noticed that the downregulation of TBPH in Drosophila muscles induced non-autonomous alterations in the structure of the presynaptic terminals with the loss of the characteristic, round and smooth, shape of the synaptic buttons ( Fig. 1h and i) . At the molecular level, we found that these morphological defects were associated with the significative reduction in the intensity levels of the presynaptic microtubule binding protein futsch, homolog to the human protein MAP1B, and responsible for the organization of the synaptic microtubule cytoskeleton ( Fig. 1j and k), suggesting that the postsynaptic function of TBPH might be mainly required for the maintenance of these structures or to prevent muscles denervation.
The muscular function of TBPH is sufficient to promote neuromuscular synapses growth and innervation
In order to further characterize the function of TBPH in skeletal muscles, we found that the genetic expression of the endogenous TBPH protein in TBPH null backgrounds (Δtb-TBPH) using the drivers Mhc-GAL4 or Mef2-GAL4, was sufficient to recover the normal locomotive behavior in larvae and adult flies ( Fig. 2a -c and Additional file 1 Fig S1) . Similarly, we found that the muscular expression of the human TDP-43 protein in TBPHnull backgrounds (Δtb-hTDP-43) was able to recover Drosophila motility suggesting that the role of these proteins in skeletal muscles must be conserved ( Fig. 2a ). On the contrary, we found that the expression of the RNA-binding deficient isoform of TBPH (TBPH F/L ) was not able to recover the TBPH-minus phenotypes demonstrating that the RNA binding ability of the protein is essential. Molecularly, we detected that the recovery of the TBPH function in the muscles of the TBPH minus flies, was sufficient to stimulate motoneurons axons growth, the formation of terminal branches and the addition of new synaptic buttons ( Fig. 2d-f ). Interestingly, we observed that the non-autonomous rescue of the presynaptic terminals was followed by the reestablishment of the evoked junction potentials (EJPs) between the motoneurons and the underlying muscles suggesting that synaptic transmission was also recovered in TBPH expressing muscles compared to controls ( Fig.  2g ). Finally, we identified that the expression of the TBPH protein in the muscles of the TBPH-null flies was able to almost completely reestablish the cytoplasmic levels and the postsynaptic distribution of Dlg around the presynaptic terminals ( Fig. 2h and i). Moreover, the results described above included the significative reorganization of the glutamate receptors in well-defined clusters at the postsynaptic membranes ( Fig. 2j and k) .
TBPH promotes the assembly of the neuromuscular synapses through the regulation of the muscular and neuronal levels of Dlg
Concerning the molecular mechanisms behind the function of TBPH in Drosophila muscles, we have described that the modulation of TBPH levels in these tissues affected the postsynaptic distribution and levels of Dlg ( Fig. 1d and e and Fig. 2h and i) suggesting that this protein may contribute to TBPH activity. In agreement with this hypothesis, we found that the mRNA sequence of Dlg presents a series of TBPH putative binding sites that suggest these molecules could physically interact. To test these possibilities, we expressed a flag tagged version of TBPH in Drosophila muscles to perform RIP assays in vivo. Interestingly, we found that TBPH was able to bind the mRNA of Dlg in pull down experiments compared to TBPH F/L (Fig. 3a ). In addition, we established that the ectopic expression of Dlg in Drosophila muscles with Mef2-GAL4, was sufficient to recover the motility problems and climbing defects described in TBPH null flies ( Fig. 3b and c). and a reestablishment of the evoked junction potentials (EJPs) between the motoneurons and the underlying muscles ( Fig. 3d ). Besides these results, we found that the muscular expression of Dlg was able to significantly recover the postsynaptic organization of the glutamate receptors at the postsynaptic, neuromuscular, membranes ( Fig. 3i and j) . Surprisingly, we observed that the postsynaptic expression of Dlg was capable to promote the nonautonomous growth of motoneurons axons indicating that Dlg is as a bona fide mediator of the signaling pathways generated or regulated by TBPH in Drosophila muscles ( Fig. 3e h). Regarding to these results, the presence of Dlg expression was also detected in motoneurons axons suggesting that TBPH might have a similar role in the regulation of Dlg expression in neuronal tissues. In support of this idea, we found that TBPH was able to bind the mRNA of Dlg in RIP assays performed in Drosophila brains after the expression of TBPH with the pan-neuronal driver elav-GAL4 ( Fig. 4a ). Moreover, we observed that Dlg appeared downregulated in adult brains of Drosophila TBPH Δ23 and TBPH Δ142 homozygous alleles compared to wildtype controls ( Fig. 4b ). Additionally, we detected that the defects in Dlg levels were recuperated following the genetic expression of the endogenous TBPH protein demonstrating that these differences were rather specific. At the functional level, we identified that the presynaptic expression of Dlg in TBPH-minus flies promoted the recovery of the locomotive problems described in TBPH-null larvae ( Fig. 4c ) and stimulated the presynaptic growth of motoneurons axons with the formation of new terminal branches and synaptic boutons ( Fig.  4d and e ). Furthermore, we noticed that the neuronal expression of Dlg induced the nonautonomous clustering of the glutamate receptors present in the postsynaptic membranes of the TBPH-minus NMJs ( Fig. 4f and g) . Altogether, the data demonstrates that TBPH regulates the pre-and postsynaptic levels of Dlg and its activity is required in muscles and neurons to promote the formation of the NMJs.
Defects in Dlg levels are conserved in human cells and motoneurons derived from ALS patients carrying mutations in TDP-43.
In order to explore whether analogous defects in Dlg levels (induced by the suppression of TBPH) are conserved in human cells, we treated SHSY5Y cells with an RNAi against TDP-43. Consequently, we found that the suppression of TDP-43 provoked the downregulation of the Dlg homolog protein PSD-95 in vitro, indicating that these regulatory mechanisms might be present and conserved in human tissues ( Fig. 5a ). Regarding to these observations, we noticed that motoneurons differentiated from iPS cell lines obtained from patients containing mutations in TDP-43, presented similar reductions in the expression levels of PSD-95 compared to healthy controls ( Fig. 5b) suggesting that analogous mechanisms could be implicated in the pathogenesis of ALS.
DISCUSSION
The atrophy and weaknesses of the body muscles is an essential characteristic of ALS that has been predominantly attributed to motoneurons degeneration. Still, studies performed in patients and experimental systems are providing indications that muscles may play a primary role in the beginnings of the disease. In this regard, we described that the muscular suppression of TBPH provoked locomotive defects with paralysis and a strong reduction in the life span. At the molecular levels, we found that TBPH was required to preserve the postsynaptic organization of the neuromuscular junctions that include the subcellular distribution of Dlg and the GluRIIA at the muscular membranes ( Fig. 1d-g ). In addition, we did not observe evident signs of muscles degeneration or atrophy after the expression of TBPH RNAi during larval development. In agreement with these results, we did not find alterations during skeletal muscles development in TBPH-null alleles, suggesting that the role of TBPH in Drosophila muscles might be restricted to the formation and differentiation of the neuromuscular synapses [19] .
TBPH supports axonal grow and postsynaptic differentiation in Drosophila muscles and is required to prevent motoneurons axons degeneration
Regarding to the evidences described above, we uncovered that the rescue of the muscular function of TBPH was sufficient to recover the molecular organization of the postsynaptic terminals, including the wild-type sharing of Dlg and GluRIIA. Moreover, we found that the muscular expression of TBPH induced the non-autonomous grow of the motoneurons axonal terminals and synaptic transmission in TBPH-minus flies, followed by the recovery of the locomotive behaviors and life span. Besides, we described that the neurotrophic characteristics of TBPH depended on the RNA-binding capacities of this protein and were conserved in the human ortholog TDP-43 suggesting that similar alterations can be expected in patients with functional defects in TDP-43.
TBPH regulates the muscular and neuronal levels of Dlg to promote the formation of the neuromuscular synapses
Regarding to the issues mentioned above, in this manuscript we described that TBPH regulates the expression levels of Dlg through direct interactions with its mRNA. Moreover, we demonstrated that these molecular interactions and regulatory mechanisms are present in skeletal muscles and motoneurons. In addition, we showed that the genetic rescue of the Dlg expression levels in the pre-or the postsynaptic compartments was sufficient to recover the neurological defects occasioned by the absence of TBPH. Regarding to that, the capacity of Dlg to recruit scaffolding and signaling proteins, through its PDZ domains, to the plasma membranes was previously described and, would explain the autonomous and non-autonomous roles of TBPH in the formation of the synaptic terminals [20] . In this context, the molecular partners of Dlg, like the adhesion protein fasciclin II, might play an important role in the synaptic-organizing functions mediated by TBPH as well as in the mechanisms of ALS. Nevertheless, further experiments would be necessary to verify these hypotheses.
In conclusion, our studies show that primary defects in TBPH function in skeletal muscles provoke locomotive problems and affect Drosophila life span. Molecularly, we describe that TBPH binds the mRNA of Dlg and regulates the expression levels of this protein in muscles and/or motoneurons to regulate the assembly and functional organization of the neuromuscular junctions. In addition, we found that these mechanisms are conserved in human cell lines and present in tissues derived from patients with ALS.
METHODS Fly strains and maintenance.
The following genotypes were used: w 1118 -w;tbph Δ23 /CyO GFP -w;tbph Δ142 /CyO GFPw;; Mef2-GAL4/TM3,Sbw;;Mhc-GAL4/TM3,Sbw;UAS-mCD8::GFP/CyOw;UAS-TBPH/CyOw;;UAS-
Wandering 3 rd instar larvae were picked from tubes and washed in a drop of demineralized water. A single larva at the time was transferred into a 10 cm diameter dish, filled with 0,7% agar. After 30 s of adaption period, the number of peristaltic waves were counted for a period of 2 min. Generally, 20 -25 larvae per genotype were tested. Survival rate. 
Immunohistchemistry.
Wandering 3 rd instar larvae were picked from fly tube, in a drop of demineralized water and selected for the genotype. Individually picked larva was dissected on Sylgard plates, in Dissection Solution (128 mM NaCl, 2 mM KCl, 4 mM MgCl2, 0,1 mM CaCl2, 35,5 mM Sucrose and 5 mM Hepes (pH 7,2)). Larvae were pinned at both ends with minute pins (Austerlic Isect Pins 0,1 mm diameter, Fine Science Tools, Germany) and opened on the dorsal site with Spring scissors (Fine Science Tools, Germany). Once larva was opened, internal organs were removed and the interior was extensively washed with Dissection Solution leaving muscle wall opened, pinned flat on the surface. The subsequent step was a fixation, generally done with 4% PFA in PBS for 20 min, however, in the case of glutamate receptors staining a methanol fixation of 5 min at -20°C was performed. Fixation solution was removed with 3 washes in PBS-T (PBS 1x supplemented with 0,1% (v/v) Tween20) for 5 min each. After a blocking step of 30 min in blocking solution (5 % NGS (Normal Goat Serum (#S-1000 Chemicon) in PBS-T buffer), larvae were incubated over night at 4°C in primary antibodies diluted in blocking solution. The day after, primary antibody was removed with three washes of 10 min each with PBS-T and a further blocking step of 30 min was performed before secondary antibodies addition. All secondary antibodies were diluted in blocking solution. An incubation was 2 h long, carried out at the room temperature. Excess of antibody was removed by 3 subsequent washes of 20 minutes each in PBS-T. Finally, dissected-stained larvae were incubated over night at 4°C in Slowfade®Gold antifade (#S36936 Life Technologies) reagent, before being mounted on a glass slide. anti-HRP (#323-005-021 Jackson 1:150), anti-GFP (#A11122 Life Technologies 1:200), anti-GluRIIA 8B4D2c (DSHB 1:15), anti-Dlg 4F3c (DSHB 1:250), anti-Futsch 22C10s (DSHB 1:50) Alexa-Fluor® 488 (mouse #A11001 or rabbit #A11008 1:500) and Alexa-Fluor® 555 (mouse #A21422 or rabbit #A21428 1:500).
Acquisition and quantification of confocal images.
In each experiment, the genotypes of interest were processed simultaneously, and the images were acquired using the same settings. Images of muscle 6 and 7 on second abdominal segment were acquired using the LSM Zeiss Software on a Zeiss 510Meta confocal microscope (63 × oil lens) and then analyzed using ImageJ (Wayne Rasband, NIH). For the quantification of pre and postsynaptic markers, samples were double labelled with anti-HRP and the marker of interest: the ratio between the mean intensity of the marker and the HRP was calculated for each bouton of the terminal.
Electrophysiology on NMJ of the third instar larva preparation.
Larval body wall preparations were dissected out in Ca2+-free HL3 solution from third instar larvae pinned on Sylgard coated petri dishes. Central nervous system was excised by cutting segmental nerves roots. After replacing Ca2+ free HL3 solution with Ca2+ 1 mM HL3, post-synaptic potentials at neuromuscular junction of fiber 6/7 of abdominal segments A3/A4 were intracellularly recorded, at room temperature in current-clamp condition, using an intracellular microelectrode (tip diameter 0.5 μm, 15 MΩ resistance). The recorded signal were amplified by a current-clamp amplifier (SEC 05, NPI, Tamm, Germany), digitized at 10 kHz sampling rate using an A/D interface (National Instruments, Austin, TX, USA) and fed to a computer for display and storage using an appropriate software (Win EDR, Strathclyde University, Glasgow, UK). Fibers with a resting membrane potential below −60 mV were considered for the experiment. In these fibers, membrane potential was set at −70 mV throughout the experiment by injecting current through the intracellular electrode. Evoked postsynaptic potentials (EPSPs or Excitatory Junctional Potentials or EJPs) were recorded by stimulating at 0.1 Hz (pulse duration 0.4 ms; 1.5 threshold voltage) the segmental nerve using a suction electrode (tip diameter ~10 μm) connected to a stimulator (S88, Grass, Pleasanton, CA, USA) through a stimulus isolation unit (SIU5, Grass, Pleasanton, CA, USA). Intracellular recordings were analyzed offline using pClamp software (pClamp, Axon, Sunnyvale, CA, USA). Statistical comparisons and graphs were made using Graphpad software (Graphpad, La Jolla, CA, USA) or MATLAB (Matworks, Natick, MA, USA).
Immunoprecipitation.
Protein G magnetic beads (#10003D Invitrogen) were washed two times with PBS + 0.02% Tween and coated with anti-FLAG M2 monoclonal antibody (#F3165 Sigma). Thoraces or heads of adult flies were cut and stored in lysis buffer containing 20 mM Hepes, 150 mM NaCl, 0.5 mM EDTA, 10% Glycerol, 0.1% Triton X-100, 1 mM DTT and protease inhibitor (#04 693 159 001 Roche). Samples were homogenized with a Dounce homogenizer, and major debris were removed by centrifugation step of 5 min at 0.4xg at 8°C. The pretreated beads and tissue extracts were mixed and incubated for 30 min at 4°C. After this binding step, beads were washed five times with washing buffer (20 mM Hepes, 150 mM NaCl, 0.5 mM EDTA, 10% Glycerol, 0.1% Triton X-100, 1 mM DTT, protease inhibitor, 0,2 % DOC, 0,5 M Urea) using DynaMagTM-Spin (#123.20D Invitrogen). RNA transcripts bound by TBPH-Flag tagged were extracted. The beads were treated with Trizol (#15596026 Ambion) and precipitated with isopropanol adding glycogen (#R0551 Thermo scientific). Retro-transcription with Superscript III First-Strand Synthesis (#18080-093 Invitrogen) was performed with Oligo-dT primers on resuspended RNA. Real Time PCR was carried out with gene specific primers, which sequences are listed below. In order to calculate the enrichment fold, initially, all data were normalized to the respective inputs. The signal was represented by how many more fold increase was measured compared to the control signal. The enrichment was calculated according to the following equation:
The results were derived from three independent immunoprecipitation experiments. Protein extraction.
To collect adult heads, flies were flash-frozen in liquid nitrogen for 10 seconds and immediately vortexed to easily detach heads from bodies. Heads were subsequently transferred into Lysis buffer (150 mM Tris, 5 mM EDTA, 10 % glycerol, 5 mM EGTA, 50 mM NaF, 4 M urea, 5 mM DTT and protease inhibitors (#04 693 159 001 Roche). After a squeezing step, performed both, manually and mechanically, the homogenized samples were gotten rid of major debris by centrifugation at 0,5 x g for 6 min on 4°C. The protein concentration of the collected supernatant was quantified with Quant-iT TM Protein Assay Kit (#Q33212 Invitrogen), following supplier protocol. Transfected neuroblastoma cell line SH-SY-5Y were resuspended in iced RIPA buffer added of protease inhibitors (#04 693 159 001 Roche) and subjected to sonication (Biorupture sonication system, Diagenode). Lysates were quantified (BCA Protein kit #23225 Thermo Scientific), following supplier protocol.
SDS-PAGE.
Protein samples were diluted in 1x Laemmli buffer (composition of 5x: 0.3 M Tris-HCl pH 6.8, 50 % glycerol, 10 % SDS, 25 % β-mercaptoethanol, 0.05 % bromophenol blue) to reach the same concentration among all and then boiled at 95°C for 5 min. Afterwards they were loaded on a polyacrylamide gel. The loaded gel was placed into chamber with 1x running buffer (10x running buffer: 30.28 g Tris, 114.13 g Glycine, 10 g SDS in 1 l water). The conditions set were 25 mA per gel. Western blot. When proteins were separated by the electrophoresis, they were transferred to a nitrocellulose membrane Amersham TM Protran TM 0.2 µm NC (Life Science). The western blot sandwich was put into the chamber, filled with transfer buffer 1x containing 20 % methanol (transfer buffer 10x: 30 g Tris, 144 g glycine in 1 l water). The transfer lasted 1 hour at 350 mA. The membrane was incubated with a solution of 5 % milk in 1x TBS 0.01 % Tween (TBS-T) for 30 min at a room temperature on a shaker (TBS buffer 10x: 24.2 g Tris, 80 g NaCl in 1 l water, pH 7.6). After blocking, the membrane was set into dilution of primary antibody with TBS-T with 5 % milk. It was placed at 4°C over night. When the incubation with primary antibodiy was over, five washes with TBS-T followed, 5 min each. Next, the membrane was incubated with the secondary antibody diluted in TBS-T with 5 % milk for 1 hour at room temperature. The protein detection was performed with SuperSignal®West Femto Maximum Sensitivity Substrate (#TB260893 Thermo Fisher Scientific). Primary antibodies: anti-Dlg 4F3c (DSHB 1:10000), anti-TBPH (home-made 1:4000), anti-tubulin (#CP06 Calbiochem 1:4000), anti-TDP-43 (#12892-1-AP Proteintech 1:4000), anti-Dlg 2D11 (#SC9961 Santa Cruz 1:1000), anti-GAPDH (#SC25778 Santa Cruz 1:2000). Secondary antibodies: anti-mouse-HRP (#31430 Thermo Fisher Scientific 1:30000(flies), 1:10000(cells)), anti-rabbit-HRP (#31460 Thermo Fisher Scientific 1:10000). Cell culture and RNA interference. SH-SY-5Y neuroblastoma cell line was cultured in standard conditions in DMEM-Glutamax (#31966-021, Thermo Fisher Scientific) supplemented 10% fetal bovine serum and 1 × antibiotic-antimycotic solution (#A5955; Sigma). RNA interference of TDP-43 was achieved using HiPerfect Transfection Reagent (#301705, Qiagen) and siRNA specific for human TDP43 (5′-gcaaagccaagaugagccu-3′); as control siRNA for Luciferase was used (5′-uaaggcuaugaagagauac-3′; Sigma). Immediately before transfection 2-4 × 105 cells were seeded in 6-well plates in 1.4 ml of medium containing 10% fetal serum. A volume of 3 μl of each siRNA (40μM solution in water), was added to 91μl of Opti-MEM I reduced serum medium (#51985-026, Thermo Fisher Scientific), incubated 5 minutes at room temperature and subsequently 6 μl of HiPerfect Transfection Reagent were added. The silencing procedure was performed again after 24 and 48 hours.
Human iPSC Culture and MN differentiation.
Human iPSC culture and MN differentiation were already described in (Romano et al., 2018) . All the studies performed with human samples were in compliance with the Code of Ethics of the World Medical association (Declaration of Helsinki) and with the national legislation and institutional guidelines. Briefly, fibroblasts from dermal biopsies (Eurobiobank) from ALS patients (TDP-43 mutations #1:G294V; #2:G378S) and controls were reprogrammed into iPSCs with CytoTune-iPS 2.0 Sendai reprogramming Kit (#A16517, ThermoFisher) and differentiated into MNs with the multistep protocol described by Ng (Ng et al., 2015) Statistical analysis. All statistical analysis was performed with Prism (GraphPad, USA) version 5.1. One-way ANOVA with Bonferroni correction and t-test with Man-Whitney correction were applied as statistical test. In all figures all the values were presented as the mean and the standard error of the mean (SEM). Statistical significance was portrayed as *p<0.05, **p<0.01, ***p<0.001.
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